TrialTrials2022

Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia.

Angela C Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.